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Ongoing efforts to quantify changes in quality of life attributable to 
low vision rehabilitation have focused on the utility of a single test instrument 
to measure this multidimensional concept. It is hypothesized that quality of 
life is best assessed using multiple instruments to capture some of its 
component facets, including functional status and psychosocial impact. Low 
vision devices have a predictably spontaneous impact on functional vision 
status, but associated psychosocial impact occurs with different magnitudes 
and over more protracted time intervals. 
The National Eye Institute Visual Function Questionnaire (NEI VFQ-
25) measures the functional status of individuals in key vision areas that are 
associated with quality of life. The Psychosocial Impact of Assistive Devices 
Scale (PIADS) is an instrument that measures the psychosocial impact of 
assistive device intervention in three quality of life domains: competence, 
adaptability, and self-esteem. 
68 participants were obtained from an ongoing parent study. These 
participants were recruited through the Low Vision Clinic at the University of 
Waterloo. They had a primary diagnosis of age-related macular degeneration 
(ARMD) and were obtaining a CCTV system for the first time. Assessments 
from the parent study used in this thesis included follow-up from 2 weeks, 1 
month, 3 months, and 6 months post-adoption of the CCTV. The two tests 
administered were to measure functional vision status (NEI VFQ-25) and 
 iii
perceived psychosocial impact (PIADS), according the framework outlined by 
the Consortium for Assistive Technology Outcomes Research (CATOR). 
Multivariate repeated-measures ANVOA results confirmed that CCTV 
systems have an immediate and robust effect on the daily visual functioning of 
their users, and that this effect is stable over long periods of device use. The 
psychosocial impact of CCTV device use peaks in the shorter term and then 
seems to wane in the longer term for reasons that are not yet understood.   
The NEI VFQ-25 and the PIADS appear to have differential sensitivity 
to important influences on low vision rehabilitation outcomes. This project 
has demonstrated the value of longitudinal outcomes research in low vision 
rehabilitation. After obtaining a CCTV, visual function status remains static 
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Chapter 1: Introduction 
1.1 Overview of the problem 
As population ages, there has been a concurrent increase in the 
prevalence of vision loss due to age-related eye conditions. One of these 
conditions is age-related macular degeneration (ARMD). Elderly people with 
ARMD face functional and psychosocial difficulties in addition to the 
physical concerns of ARMD. Reading difficulty is one of the most prominent 
concerns as it affects independence and quality of life. The closed-circuit 
television device (CCTV) is one important device to assist people with 
ARMD-related vision loss. Data on the longitudinal impact of newly acquired 
CCTV devices on the quality of life for ARMD-related low vision patients is 
scarce. Understanding the entirety of the impact of CCTV devices is important 
for the future direction of rehabilitative services.  
The rapidly aging population has contributed to an increased pressure 
on medical care and other social services. A significant factor in this aging 
population is the large number of baby boomers (those born between 1946 and 
1962) who are approaching retirement age. The 2006 Census indicates that the 
65-and-over population made a record of 13.7 % of the total population of 
Canada.2 Also, a new record of 3.7 million Canadians age 55 to 64 were 
recorded (many of whom are workers approaching retirement).2 The demand 
for health care is increasing faster than the resources available to provide 
services due to the aging of the population, the development of new 
 1
knowledge and technology, and the heightened awareness and expectations of 
patients and professionals.3 A better understanding of the impact of assistive 
devices on people with ARMD and how it changes over time will allow us to 
develop a better plan for dealing with these people as their numbers increase 
in the future. 
The increased number of elderly people is associated with an increased 
prevalence of ARMD within the population. ARMD is the most common 
cause of irresolvable vision in elderly population; consequently, there will be 
increased numbers of people with ARMD-related low vision seeking 
rehabilitation services and assistive devices. The elderly are 
disproportionately affected by vision loss. Individuals over the age of 65 years 
experience more vision loss than any other age group.4 Next to arthritis, vision 
impairment is the most common cause of disability in the elderly.4 When 
decrements in vision occur, they compromise an older person’s ability to carry 
out routine activities, diminish overall function, and decrease quality of life.4, 5 
Many of the negative consequences of vision loss (such as those of ARMD) 
can be mitigated by rehabilitation, and needless suffering can be diminished. 
Given the association between age and vision loss, the demand for low vision 
rehabilitative services will increase significantly.3 In order to provide better 
rehabilitative care, it is important to address the issues related to the impact of 
assistive devices on people with ARMD-related low vision. With the 
increasing number of elderly persons with ARMD and with the increasing 
pressure this creates on rehabilitation resources, finding measurement tools 
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which reflect the visual function status and the psychosocial impact 
experienced by those who have received a CCTV (through the rehabilitative 
process) is critical in order to improve rehabilitative services. Psychosocial 
impact refers factors within the individual person and to factors related to the 
environment that affects the psychological adjustment of an individual with a 
disability.6 Understanding of the functional and psychosocial factors will 
contribute to improved outcomes for device adoption and retention.6 
The impact of ARMD-related low vision has been investigated 
through a variety of studies; however no study has specifically looked at the 
longitudinal impact of assistive devices for people with age-related macular 
degeneration. Studies pertaining to ARMD are: quality of life studies,7-10 low 
vision rehabilitation studies,4, 11, 12 and studies assessing visual function.13-16 In 
a clinical setting, measurements such as visual acuity and contrast sensitivity 
are used to assess the severity of ARMD, but these measures may be poor 
indicators of the overall impact of the disease on a person’s life. This has led 
to an increased interest in measuring quality of life for people with ARMD. In 
clinical vision rehabilitation settings, patients are provided the opportunity to 
be assessed functionally with assistive devices such as CCTV devices. Due to 
the lack of longitudinal research for the impact of assistive devices, there is 
limited information about how the CCTV affects a person’s life after leaving 
the clinic. Longitudinal research can show the changes which occur over time 
while the patient uses her/his CCTV.  
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Assessing the longitudinal impact of newly acquired CCTV devices on 
quality of life for low vision patients with ARMD will allow us to better 
understand the impact of assistive devices (CCTV) and to identify missing 
gaps in current research. We need to understand the impact of such devices on 
people with ARMD. Important concepts, terminology, and background 
information will be covered including: age-related macular degeneration low 
vision, low vision rehabilitation, assistive devices, quality of life, outcomes 
research, models in outcomes research and measurement tools in outcomes 
research. 
1.2 Age-Related Macular Degeneration Low Vision 
Age-related macular degeneration (ARMD) is the leading cause of 
vision loss in the industrial world.17 A full understanding of the impact of 
ARMD low vision includes the understanding of the two main classifications 
of ARMD (wet and dry), treatment options, and the population affected. 
Finally, it is important to comprehend how functional vision and quality of 
life is affected by ARMD. 
Dry ARMD occurs as a result of accumulation of deposits (drusen) on 
the central retina followed by the gradual loss of photoreceptors, which is 
accompanied by a gradual reduction in visual acuity.18 Dry ARMD may lead 
to profound loss of photoreceptors in the central retina (geographic atrophy).18 
Wet ARMD or exudative ARMD occurs when blood vessels invade the retina 
from below in the macular region.18 The progression of wet ARMD is much 
faster compared to dry ARMD. As the condition progresses, a non-seeing area 
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(scotoma), distortion, or relative loss of sensitivity may develop in the central 
field of vision. People with central scotoma must use eccentric retinal areas to 
perform visual tasks that the non-functioning (or impaired) fovea used to 
perform.19 According the National Eye Institute (US), 1.5% of Americans 
have advanced ARMD, and 6.1% of Americans have intermediate ARMD.20  
The prevalence increases directly with age; the largest proportion of ARMD is 
in people over the age of 80 years old.20 The population prevalence and 
incidence of ARMD are likely to increase dramatically with the aging 
population – some estimates state by 50%.21 The ratio of patients diagnosed 
with dry versus wet ARMD has been typically reported as about 90% versus 
10% respectively.19 Although more people have dry ARMD, indications are 
that the prevalence of people referred to vision rehabilitation services by dry 
versus wet ARMD is nearly 50-50.19 
Treatments available for ARMD are relevant for a select group of 
patients, for whom the treatments primarily slow or arrest the progression of 
vision loss.7 Recent advances have improved the efficacy of treatments, but 
vision still cannot be restored to a “normal” level of functioning. Recent 
treatments have been somewhat more effective at restoring some vision, but 
not to the previous level. For wet ARMD, treatment options include laser 
surgery, photodynamic therapy, and intravitreal injections. The results of 
treatments for dry ARMD indicates that high-dose formulations of 
antioxidants and zinc may significantly reduce the risk of advanced ARMD 
and its associated vision loss.22 Nevertheless, people with both types of 
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ARMD have the option of seeking rehabilitative care in order to maximize 
their remaining visual function.  
Many definitions of low vision pose a challenge because they are 
based on how treatable a disorder may be.21 The term “vision loss” may 
include modest low vision to total blindness, whereas “low vision” indicates 
that the person is not functionally blind and that the vision is less than 
normal.21 Low vision is defined as any condition of diminished vision not 
correctable by standard glasses, contact lenses, medication or surgery that 
disrupts a person’s ability to perform common age-appropriate visual tasks.21 
With ARMD-related low vision, central vision may be lost but the person 
always retains a significant amount of peripheral vision, and treatments are 
most effective in slowing the progression of vision loss.  
The impact of ARMD-related low vision is detrimental to the well-
being of a person. Blindness is one of the three leading fears of Americans, 
after cancer and AIDS/HIV.23 Vision loss interferes with instrumental 
activities of daily living and social function, leisure activities, and mobility. 
ARMD can make daily activities such as reading, driving, recognizing people, 
and cooking extremely difficult or impossible. Vision loss has been linked to 
an increase in hip fractures, falls, and depression.24 There is an increase in 
physician visits, hospitalizations, mortality, and family stress.5 Patients with 
ARMD are more likely than their normally sighted peers to need help with 
daily activities.25 Severity of ARMD is associated with poorer scores for near 
vision activities and driving.25 The limitations and frustrations experienced by 
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people with low vision can result in depression and, in many cases, a 
deterioration in general health.26 Research has shown that visual impairment is 
significantly associated with decreased functional status, diminished self-
reported quality of life, and increased emotional distress.25 Fortunately, there 
is a possibility of people returning to active, productive, and independent life 
styles with the assistance of low vision aids and rehabilitative training.26  It is 
estimated that ninety percent of individuals with significant vision loss may 
benefit from vision rehabilitation that includes enhancement of adaptive skills 
and training in the use of optical and non-optical low vision devices.4   
When a person experiences increased difficulty in performing daily 
living tasks, her or his physical, functional, and psychosocial life is affected. 
In order to improve the rehabilitative process for persons with ARMD-related 
low vision, it is important to understand the impact of rehabilitation on the 
functional and psychosocial aspects of their lives. 
1.3 Low Vision Rehabilitation 
Low vision rehabilitation provides opportunities for people affected by 
ARMD-related low vision by offering a wide range of devices and training. 
Rehabilitation was defined by the World Health Organization (WHO) as a 
process aimed at enabling persons with disabilities to reach and maintain their 
optimal functional levels.27 With the development of the International 
Classification of Functioning, Disability and Health (ICF), the definition of 
rehabilitation was broadened to recognize the personal and environmental 
factors directly influencing the experience of people with disabilities. 
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Currently, rehabilitation is considered to be a coordinated process that 
enhances activity and participation.1 
The primary objectives of low vision rehabilitation are to maximize 
functional independence, to maintain quality of life, and to help people adapt 
to the psychosocial aspects of vision loss. The requisite interventions may 
include assistive devices, training, and counselling services.25 At the outset, it 
is important to ensure that the causal medical eye condition is evaluated and 
treated in order to maintain and maximize the patient’s visual potential. 
People are then trained to use their residual vision more effectively. Services 
also may include practical environmental adaptations to facilitate activities of 
daily living, to ensure safety, and to maintain independence. Rehabilitation 
uses assistive technology, adaptive skills, and environmental modifications.28 
All of these techniques increase independence, reduce stress and depression, 
improve mobility, and increase quality of life.29 
Another goal for rehabilitation is to provide the individual with some 
functional reserve capability. Functional reserve is the difference between the 
patient’s-total visual ability and the actual visual ability that is required to 
perform an activity.30, 31 For example, a person may be able newspaper text 
using a 4x magnifier, but an 8x magnifier often provides enhanced reading 
proficiency, which may mean that the person can read more comfortably and 
for a longer period. To be functionally independent, individuals must be able 
to perform activities that allow them to maintain themselves in their habitual 
environment.30 Inability to perform desired activities may have negative 
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impact on some or all of the following: daily living, social interaction, 
recreational, vocational, and educational.30 Functional reserve for a given 
activity can be increased by increasing the visual ability of the patient or by 
decreasing the visual ability needed to perform the activity.  
Successful low vision rehabilitation alters the relationship between 
visual impairments and their consequent visual disabilities. The level of visual 
impairment may remain stable (visual acuity, contrast sensitivity, and visual 
field defect), but the person’s ability to perform vision related tasks is 
improved due to vision rehabilitation (which may or may not include training 
and assistive device use).32 Vision rehabilitation is a multidimensional 
learning process in which a patient must acquire new skills, change behavior 
patterns, grieve the loss of normal vision, and make the emotional shift from a 
normal sighted to a visually impaired person.4 These changes go well beyond 
evaluation and prescription of devices. 
With the definition of low vision rehabilitation (a coordinated process 
that enhances activity and participation) we are able to specify the goals of 
rehabilitation and assistive use. Those goals are: to maximize functional 
independence, to maintain quality of life, to help a patient adapt to the 
psychosocial aspects of vision loss, and to improve functional reserve.  
1.4 Assistive Devices 
An important component in vision rehabilitation is the assessment and 
provision of assistive devices. Most people use some form of assistive 
technology on a daily basis. Whether it is a computer, glasses, or even our can 
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opener, we are using devices to help us in every day tasks. Assistive 
technology includes structural alterations, special equipment, assistive 
devices, material adjustment, or environmentally-based behavioral 
modifications.33 Assistive technology is recognized as one environmental 
factor which can have a major impact on activities and participation.12 It 
provides a means for circumventing barriers (such as inability to read), which 
subsequently increases activity participation.34 Persons use assistive 
technology in order to gain access to, operate within, move through, and/or 
have an effect on their physical and social environments.34 Older adults use 
assistive technology to diminish the disabling effects of illness and the 
physiological and cognitive changes due to ageing.34    
Assistive devices are applied to, or directly manipulated by, a person; 
e.g. wheelchairs, reaching devices, voice-output communication aids, and 
hearing or vision aids.33 They are considered essential to the health and well-
being of all people, but especially people with sensory or physical 
disabilities.35 Studies have shown that persons with visual impairment are 
more dependent in daily activities than persons with normal vision at the same 
age.12 For example, approximately 25% of persons aged 65 years and older 
own an assistive device and about one-third of these people own multiple 
devices.34  
Low vision assistive devices are assistive devices that are specifically 
designed for people who have low vision. Examples of low vision assistive 
devices are magnifiers, telescopes/binoculars, glare control devices, closed-
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circuit television (CCTV) devices, or adapted computer systems. Ninety 
percent of seniors over 75 years of age who reported vision limitations also 
reported using vision aids.36  
 As described earlier, people with ARMD often experience some 
amount of central vision loss which interferes with high visual acuity tasks 
such as reading. A major rehabilitation objective for someone with ARMD-
related low vision is to be able to read normal sized print/text. In order to do 
this, many people require some form of magnification device, such as an 
optical magnifier or a CCTV system. Other commonly prescribed devices 
help people with ARMD cope with glare. For example lenses with selective 
transmission properties in them and proper illumination control are strategies 
for lessening glare and increasing contrast. CCTV devices were chose for 
research in this study because they are versatile and effective devices with 
demonstrated potential utility for a broad range of impairment presentations 
and task activities.32  
CCTV assessments are conducted in accordance with a competitive 
enablement approach. Competitive enablement is “a conceptual approach 
wherein the functional impact of competing device interventions is evaluated 
by individual patients while performing a series of self-identified problematic 
tasks having high functional relevance to the individuals themselves”.32 Using 
a competitive enablement approach to selecting devices allows the patient to 
have side-by-side comparisons of the devices to decide which device is most 
appropriate for the activities she/he feels are important.    
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Technology assisted rehabilitation using CCTV devices is intended to 
promote a healthy outcome by adoption of the CCTV, acceptance of the 
CCTV and adherence to its prescription, and satisfaction with the CCTV.37 
The decision-making process for older adults who are contemplating the use 
of assistive technology is influenced by various personal factors. These 
include whether the assistive technology will serve as an effective strategy for 
coping with their limitations, the preservation of preferred self-image, and/or 
the degree of importance attributed to independence, control and cost savings. 
The competitive enablement approach allows the person to evaluate various 
CCTV models in order to determine whether the CCTV will meet their 
personal needs. CCTV use may promote increased participation, which 
provides a basis for coping with and adapting to barriers, improves function, 
and may enhance quality of life.34, 38 
Contemporary research is investigating the success of rehabilitation 
using assistive devices. Dahlin-Ivanoff et al. (2004) found a high proportion 
of assistive device users among the visually impaired population and these 
users reported assistive devices to be important tools in their attempts to 
remain independent in daily living.12 Mann (2002) found that device 
effectiveness (for maximizing independence) plays an important role in 
determining whether people with severe visual impairments view assistive 
technology as an effective or ineffective strategy for coping with limitations.34 
Mann (2002) suggests that employing healthy or unhealthy coping strategies 
is a personal choice and will influence assistive technology use or non-use.34 
 12
Specific to CCTV devices, it has been shown that CCTV devices provide 
substantial psychosocial benefit to patients with low vision.32 Reading speed 
and endurance are improved significantly with CCTV systems in comparison 
with prescribed optical devices for participants whose primary diagnosis was 
ARMD.39 The CCTV has been shown to be a successful device in assisting 
people with ARMD and improving their quality of life. 
1.5 Quality of Life 
As mentioned previously, the goal of technology assisted rehabilitation 
is to improve quality of life. The definition of quality of life has evolved over 
time. Quality of life has been measured in the form of assets and 
environmental conditions and it has been viewed as the impact of assets on 
one’s emotions and mood (i.e. happiness and well-being).25, 37 The limitation 
of these perspectives is that they are more descriptive of a standard of living.37 
In the health care field, quality of life is measured as health-related quality of 
life. Health-related quality of life is more focused on assessing health status or 
change in health status and not the impact of rehabilitation.6 The limitation 
with this perspective is that it is too medically orientated.6 CCTV devices are 
not intended to promote health or healing, but rather to improve functional 
capabilities. In order to obtain a definition of quality of life which would be 
suitable to someone affected with low vision, the assumption has been made 
that quality of life is complex, a multidimensional construct, dynamic, 
changing over time, and changing over a person’s life.6 Quality of life arises 
from a person’s interaction with their environment and it is experienced 
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differently from person to person, but it has the same components for 
everyone.40 For the purposes of this research, quality of life is defined the 
degree to which a person enjoys the important possibilities of their life.37  
Vision-related quality of life is often measured by means such as 
cognitive functioning, depression, activities of daily living, or social 
functioning.25 The value of these criteria lies in the ability to assess selected 
parameters in depth.25 These vision specific quality of life measures provide 
an overview of the effect of the condition related to the visual impairment.41 
To understand low vision rehabilitation and to measure the effects of 
intervention, we must be able to measure visual impairment. Obviously, such 
measurements must be based on measurements of visual ability.41 Therefore 
vision-specific quality of life is the subjective interpretation of the patient’s 
visual ability since her/his vision has been affected by a condition such as 
ARMD. 
Vision-related quality of life is not the same as functional vision. Two 
people with the same degree of functional vision do not necessarily have the 
same quality of life. Similarly, two people with the same functional vision 
receiving the same assistive device may report different impacts because the 
device affects different aspects of their quality of life. Another important 
feature to understand about quality of life is that it changes throughout a 
person’s life. Therefore, it is imperative to evaluate quality of life over time in 
order to track any changes that are occurring. If a test is administered only at 
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one point in time, any changes experienced by the person (such as someone 
with ARMD who has received a CCTV) over time will not be recognized.  
Assistive devices such as the CCTV are shown to have a positive 
impact on quality of life in areas of functional status and psychosocial 
impact.32 An assistive device should promote good quality of life for the user 
to the extent to which it makes the user feel competent, confident, and 
inclined (or motivated) to exploit life’s possibilities.37 Subjective 
measurements of quality of life are imperative because changes in the 
patient’s own perception of his or her quality of life is one of the most 
meaningful intervention outcomes.31  
A longitudinal study on quality of life is necessary to monitor and 
understand changes after a person receives an assistive device such as a 
CCTV. Quality of life in this study is seen as the effect of the devices on the 
degree to which a person enjoys the important possibilities of their life. The 
loss of reading is typically a major complaint for people with ARMD-related 
low vision. By using measurement tools to assess the longitudinal 
psychosocial impact and functional status of a person with ARMD-related low 
vision, we can comprehend the changes in quality of life which occurs after 
obtaining a CCTV device to restore lost reading capability. 
1.6 Outcomes Research 
Outcomes research serves several functions in evaluating the 
interventions recommended by providers whose intention is to assist 
individuals in improving their quality of life. Outcomes research is concerned 
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with verifying that the interventions are causally responsible for observed 
changes in the targeted individuals or populations and with developing an 
improved understanding of these causal relationships.42 Outcome research 
helps answer questions such as what services work, under what particular 
conditions, for what service recipients.43 Patient-based outcomes, that measure 
constructs such as health-related quality of life, subjective health status, and 
functional status, are used increasingly as primary or secondary end-points in 
clinical trials.44  
Outcomes research – specifically assistive technology outcomes 
research – uses systematic investigations to identify changes that are produced 
by assistive technology in the lives of users and their environments.33 An ideal 
model for rehabilitation treatment would explain why particular interventions 
achieve the outcomes they do.33 Low vision outcomes must be studied with 
the same rigor as other medical treatments to develop an evidentiary basis to 
guide policy and funding decisions.3 Although it is incontrovertible that many 
patients can improve their performance with low-vision devices, not all 
patients are successful device users. In the evaluation of outcomes, some 
studies have recognized this difference between efficacy (the ability to 
perform tasks in the clinic) and effectiveness (the use of devise and skills in 
everyday life, once the patience returns home).45 Outcomes research provides 
an avenue for studying the link between rehabilitation, assistive devices, and a 
person’s perspective on quality of life. 
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Outcomes research is essential for understanding participants with 
ARMD-related low vision who use CCTV devices to improve their quality of 
life. 
1.7 International Classification of Functioning, 
Disability, and Health (ICF) 
The International Classification of Functioning, Disability and Health 
(ICF) is one conceptual framework which can be used in order to understand 
the impact of assistive device use in patients with low vision. It is important to 
understand what the ICF is describing and how it differs from past models.  
The International Classification of Functioning, Disability and Health 
(ICF) was developed in response to the shortcomings of the predecessor 
model of the International Classification of Impairments, Disabilities, and 
Handicaps.46 The overall aim of the ICF classification is to provide a unified 
standard language and framework for the description of health and health-
related status.1 It defines components of health and some health- related 
components of well-being.1 The ICF differs from the original 1980 model in 
that it has two essential factors, each with two subcomponents: (1) 
Functioning and disability – body functions and structure; activities and 
participation; (2) Contextual factors - environmental factors, and personal 
factors.1 These domains interact with each other and are influenced by both 
environmental and personal factors.46 Functioning is an umbrella term 
encompassing all body functions, activities and participation. Disabilities 
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serves as an umbrella term for impairments, activity limitations or 
participation restrictions.1 The concept of the ICF is listed in Table 1. 
Table 1: An overview of ICF 1  
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The concepts of the ICF are useful in portraying the multidimensional 
experience of older people who report vision loss.46 The ICF provides a 
broader model for health. Research has started to focus on how the ICF might 
explain health outcomes across a spectrum of health conditions.47 The ICF 
takes a neutral stand with regard to etiology, so researchers can draw casual 
inferences using appropriate scientific methods.1 The ICF framework has the 
potential to provide a universal, standardized, disablement language and a 
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framework that looks beyond mortality and disease to focus on how people 
live with their conditions.48 Figure 1 provides an illustration of the ICF model 
applied to age-related macular degeneration. 
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Figure 1: International Classification of Functioning (ICF) model applied 
to age-related macular degeneration 1  
 
By applying the concepts of the ICF, one is able to explore the various 
components associated with ARMD-related low vision.   
1.8 The Consortium for Assistive Technology 
Outcomes Research 
The ICF does not model the ‘process’ of functioning and disability, but 
it does provide the building blocks for users who wish to create models and 
study different aspects of this process.1 One such framework, which uses the 
ICF as its building block, is the Consortium for Assistive Technology 
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Outcomes Research (CATOR) framework. The CATOR framework and the 
CATOR taxonomy for modeling the outcomes of assistive technology 
intervention embraces the ICF framework and describes the sequence of 
possible outcomes experienced by an individual after procuring an assistive 
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Figure 2: The CATOR framework for modeling the outcomes of assistive 
technology  
 
The CATOR taxonomy is used to map the outcome areas defined by 
the CATOR framework and the ICF components into a single, hierarchical 
classification scheme.42 The procurement of a device-type is as a result of a 
progressed health condition – for example ARMD, followed by impairment, 
activity limitation, and participation restriction. Low vision rehabilitation uses 
assistive devices which are appropriate for the tasks affected by a person’s 
disability such as the CCTV system. A key component to this framework is 
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recognizing it is a time-dependent framework. There are two stages involved - 
an initial stage associated with dispensing of the device and a longer term 
stage associated with events after dispensing.33 The outcome measures are 
identical at the shorter term and longer term outcomes (see Figure 2). The 
CATOR framework implies that those dimensions measured in the shorter and 
longer term outcomes can change. For example, at introductory use the 
participant may continue to use their device, but when measured at the longer 
term, the reported outcomes may have changed. Therefore we see different 
results in the longer term outcomes compared the to shorter term outcomes.  
The CATOR framework can be used as a predictor of device use as well it 
demonstrates the importance of measuring at various times in order to 
understand the changes occurring post-adoption. The CATOR framework 
proposes that every form of assistive technology outcome can be slotted 
uniquely into one of the three subordinate vantages: effectiveness (how 
assistive devices might affect users’ functioning or change in health 
condition), social significance (the meaning that society attaches to 
effectiveness outcomes), and subjective well-being (subjective quality of life, 
how the assistive devices affects their lives).33 
In accordance with the CATOR framework, the subjective quality of 
life outcomes for participants with ARMD who obtained a CCTV can be 
tracked and analyzed to model the impact of these devices. The NEI VFQ-25 
and the PIADS are examples of relevant measurement tools which will be 
discussed in subsequent sections. By administering these measurement tools 
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in a longitudinal study, the shorter term and longer term outcomes will be 
reported. 
1.9 The National Eye Institute 25 Item Visual 
Function Questionnaire 
The National Eye Institute 25 Item Visual Function Questionnaire 
(NEI VFQ-25) is a vision-targeted survey that assesses the influence of visual 
impairment on health-related quality of life.49 In this section, the creation, 
purpose, validity, and reliability of the NEI VFQ-25 will be explained. Also, 
how the NEI VFQ-25 relates to the CATOR framework will be explained. 
Finally, the advantages and disadvantages of vision specific questionnaires 
will be explained. 
The NEI VFQ-25 originally was a fifty one question survey, the NEI 
VFQ-51. The contents were derived empirically from a multi-condition focus 
group process.50 The majority of the items from the longer version were 
dropped based on linear regression models to the 25 question version.49 The 
25 question version was developed to preserve the multidimensional content, 
reliability, and the validly of the full length version, but it was changed in 
order for it to be preformed in about 5 minutes.49 In general, it was intended to 
measure “functioning and well-being in physical, mental, and social health 
realms of life and reflects the influence of a broad range of health conditions 
simultaneously”.49 Specifically, the NEI VFQ-25 survey is designed to 
measure the influence of visual symptoms and visual disability on generic 
health domains such as emotional well-being and social functioning, in 
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addition to task-oriented domains related to daily visual functioning.49 This 
scale attempts to address the limitations of traditional by health related 
questionnaires, because it is designed specifically for individuals with vision 
disabilities.  
This is a 25-item survey that covers areas of general health, general 
vision, ocular pain, and vision specific tasks.49 These subscales are 
transformed to 0 - 100 scales, where 100 represents the best possible score, 
and 0 represents the worst.49 The subscale scores are generated as 
independent, function-specific measures of visual functioning. After 
completing all computations, there are 12 subscale items - general health, 
general vision, ocular pain, near activities, distance activities, social 
functioning, mental health, role difficulties, dependency, driving, colour 
vision, and peripheral vision.  
The NEI VFQ-25 has been shown to be valid and reliable. It has been 
used to show that those with ocular disease and accompanying visual 
impairment have lower scores compared to a reference group without ocular 
disease or visual impairment.23, 49, 51-54 This scale has been used to assess 
quality of life of those with uncorrected refractive error.55 The NEI VFQ-25 
has been used to assess self-reported visual impairment in patients with 
multiple sclerosis.56 NEI VFQ-25 has been validated in populations of patients 
with diverse sets of eye diseases.23 Most importantly, the NEI VFQ-25 has 
been found to be suitable in measuring the health-related quality of life issues 
in patients with ARMD.7  
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The importance of the NEI VFQ-25 for this research is that it is 
designed to capture functional status of individuals in key areas that are 
associated with quality of life, that is, it is able to capture some of the 
outcomes outlined by the CATOR framework. The NEI VFQ-25 is able to 
specifically assess the shorter term outcomes described in the CATOR 
framework. For the purposes of this research study, the NEI VFQ-25 was used 
as a status measure to monitor for any the functional vision changes over six-
months. 
The advantages of condition-specific surveys, such as the NEI VFQ-
25, is that they are intended to have relevant content when used in trials for a 
specific disease, they are more likely to detect important changes that occur 
over time in the particular disease studied, and they are more acceptable to 
patients because they are clearly relevant to the patients’ presenting 
problem.44 A major disadvantage of condition-specific questionnaires is that 
they preclude any obvious or easy comparison with outcomes of different 
treatments for patients with different health problems.44 Also, they may 
overlook any health problems or treatment issues that were not anticipated 
when the instrument was designed. An instrument with a broader range of 
items may be more likely to detect such unexpected effects.44 The questions 
on the NEI VFQ-25 that require difficulty ratings for specific activities are 
likely to be selectively sensitive to the effects of interventions targeted to 
easing the performance of those activities. In other words, a question about 
reading difficulty will be sensitive to device interventions to help with 
 24
reading.  In contrast, the more general questions are likely to be sensitive only 
to changes in the patient’s visual ability or to targeted reduction in difficulty 
in a broad range of activities (based on functional reserve).31   
1.10 Psychosocial Impact of Assistive Devices Scale 
(PIADS) 
The other measurement tool which can be used to asses the outcomes 
described by the CATOR is the Psychosocial Impact of Assistive Devices 
Scale (PIADS). There are advantages and disadvantages to using a generic 
application such as the PIADS. It is for this reason that the PIADS and the 
NEI VFQ-25 was used together to compile their strengths and counteract their 
disadvantages. 
PIADS items were created from three principal sources: empirical 
explorations with the Pleasure-Arousal-Dominance scale; qualitative research 
(focus groups) wherein assistive technology users were asked to describe how 
they expected devices to impact their quality of life; and the literature on 
personality research.6 The goal of the PIADS is to measure the impact of an 
assistive device (such as the CCTV) on functional independence, well-being, 
and quality of life.6, 35 The PIADS is a 26-item questionnaire which measures 
the psychosocial impact of assistive device intervention in three quality of life 
domains – competence, adaptability, and self-esteem. Competence measures 
feelings of efficacy where it is sensitive to the perceived impacts of assistive 
technology on performance and productivity.6 Adaptability indicates a 
willingness to try out new things and to take risks. This measure is sensitive to 
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the enabling and liberating aspects of assistive technology that might be 
expected if assistive devices enhanced participation.6 Finally, self-esteem 
indicates feelings of emotional health and happiness, and is sensitive to the 
perceived impact of assistive technology on self-confidence and emotional 
well-being.6 Scores can rage from -3 (max. negative impact) to zero (no 
perceived impact) up to +3 (max. positive impact).35 Psychosocial impact 
refers to both factors within the person and factors attributable to the 
environment that affect the psychological adjustment of individual who have a 
disability.35  
This scale has been shown to be a reliable, valid and responsive 
measure.35, 38, 57 This scale has been successfully translated into Canadian-
French.59 This scale has been shown to be valid and reliable in assessing 
quality of life and functional status in participants who have undergone a 
stapedotomy.58 The PIADS has successfully been used in other device areas 
such as hearing aid, mobility aids, visual aids, and electronic aids.57, 60-62  
The PIADS was chosen to measure the psychosocial impact of CCTV 
users because it is able to capture the longer term outcomes outlined by the 
CATOR framework. As explained previously, the CATOR framework is a 
time dependent framework. Therefore, not all of the outcomes may be 
experienced at an initial assessment. The NEI VFQ-25 is able to capture the 
early outcomes such as effectiveness of the device, efficiency, and device 
satisfaction. The PIADS designed so that it is able to capture the elements of 
the psychological functioning and subjective well-being. 
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The advantage of a generic questionnaire, such as the PIADS, is that it 
can be used for a broad range of health problems, it enables comparison across 
treatments for groups of patients with different conditions, and has the 
capacity to detect and measure unexpected positive or negative effects of an 
intervention (such as the impact of assistive devices).23, 44 Another advantage 
is they reduce patient burden produced by completing a number of 
questionnaires. A more general body of experience and comparative evidence 
could emerge to enhance the value and interpretability of patient based 
outcome measures.44 However generic questionnaires have a disadvantage in 
that they must sacrifice some level of detail in terms of relevance to any one 
illness, they would have fewer relevant items to the particular disease and 
intervention and therefore be less sensitive to change that might occur as a 
result of an intervention.44  
It has been recommended that researchers include a generic measure 
together with disease-specific measure in order to overcome the disadvantages 
of using generic applications and a vision specific applications in isolation 
(therefore making the results stronger by having both present).44 The main 
argument for such an approach is that the two kinds of measures are likely to 
produce complementary evidence and may also detect unexpected positive or 
negative effects of a novel intervention.44 By combining both the NEI VFQ-25 
and the PIADS, it is possible to measure the changes in functional vision 
status and the psychosocial impact of technology-assisted rehabilitation for 
those affected by ARMD. Self-reported visual function and quality of life 
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measures have become useful adjuncts for evaluating the impact of a patient’s 
visual functioning or disease state on that particular individual and the effects 
of rehabilitation on the individual’s level of function.23 Combining both the 
NEI VFQ-25 and the PIADS allows us to evaluate the short and long term 
outcomes experienced by CCTV users can be measured in accordance with 
the CATOR framework. 
This research is needed to advance our understanding of the process by 
which ARMD-related low vision patients successfully adopt and use low 
vision assistive devices like CCTV devices. In doing so, we may discover new 
opportunities for more effective clinical interventions at various points within 
the rehabilitation process. 
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Chapter 2: Research Hypotheses  
A CCTV system can be used to assist those with ARMD-related low 
vision, specifically by improving their reading ability. In accordance with the 
ICF model, one expects the CCTV will have a direct impact on the user’s 
functional abilities, and thus this improved ability will have a consequential 
impact on the user’s psychosocial status. This research project hypothesized 
that assistive devices will have immediate and robust impact on functional 
vision status, but that psychosocial impact will be delayed over the period 
following device adoption. The functional status change is expected to occur 
first because the assessment and prescribing protocols (competitive 
enablement) ensure that the device will redress the functional deficit reported 
by the presenting patient. The full psychosocial impact of the CCTV will be 
delayed as the patient has an opportunity to experience the benefits of the 
device and how it impacts on daily living. 
Accordingly we expect: 
1) The NEI VFQ-25 scores will indicate impact on functional status 
following CCTV adoption indicating successful rehabilitation.  
2) The NEI VFQ-25 scores will remain stable over the study period of six 
months. 
3) The PIADS scores will indicate positive psychosocial impact 
following CCTV adoption.  
4) The PIADS scores will increase over the ensuring period. 
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Chapter 3: Methods 
3.1 Participants 
Data for this research were obtained from a host cohort study of low 
vision device outcomes entitled “Dynamic program approach to modeling 
assistive technology device outcomes in low vision rehabilitation”, funded by 
the CIHR (grant # MOP-74522). Participants were first time patients over the 
age of 18 years who attended the University of Waterloo Low Vision Clinic. 
They were recruited sequentially from consecutive appointments at the Low 
Vision Clinic. The reason for selection of first time participants was to include 
persons who would have little to no experience with assistive devices. Due to 
linguistic complexities of the measurement tools, the youngest age allowed 
into the host study was 18 years. 
Potential participants were approached by a trained recruiter on the 
day of their Low Vision Clinic assessment. Details of the study were 
explained to participants and each participant was given a large print 
information letter that described the study being conducted. They were able to 
ask any questions about the study. If they agreed to participate, they were 
asked to sign a consent form confirming their agreement. For those patients 
who refused to take part, their reasons were noted and recorded in a database. 
After a person completed his or her low vision clinical assessment, the 
clinic file was reviewed and data was collected from the low vision patient 
record. This included information such as gender, age, living circumstance, 
and support. 
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Participants were contacted two weeks after their clinic visit to 
confirm that they had received and were using their prescribed devices. The 
host study allowed for anyone new to the clinic and over 18 years to enter the 
study as long as they have received a low vision device. If they had not yet 
received their low vision device, a subsequent contact time was arranged to 
ensure they were using their device before taking part in the first assessment. 
Data collection was administered by telephone interview for both the PIADS 
and the NEI VFQ-25. Participants were contacted for follow-up assessment 
biweekly for six months and then monthly for six months to assure the capture 
of significant changes throughout the one year of assessments. At the end of 
one year of assessments, participants would have completed 18 assessments. 
For the purposes of this thesis, the data from the host study were 
filtered to identify only participants with ARMD, who were new CCTV users, 
and who had completed at least six-months of assessments.  Participants had 
little to no experience using a CCTV system prior to the study. The data 
collected were the initial (2-weeks), 1 month, 3 months, and six months 
assessments. Figure 3 shows a flow chart on how participants were filtered 
from the host study to be included into this research. Of the 231 participants 
of the host study, only 68 participants were eligible for this study. Of these, 47 
had wet ARMD and 21 had dry ARMD. 
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Recruited (enrolled 
into host study) 
n = 231 
ARMD 
n = 151 
Non-ARMD 
n = 80 
Completed 6 months 
of data 
n = 90  
Haven’t completed 6 
months of data 
n = 61 
Completed 6 months 
of data 
n = 46  
Haven’t completed 6 
months of data 
n = 34 
Non-CCTV 
user 
n = 22 
Non-CCTV 
user 
n = 7 
Wet ARMD
n = 47 
CCTV user 
n = 39 CCTV user
n = 68  
Dry ARMD
n = 21 
 
Figure 3: Flow chart of how data from host study was filtered for the 
purposes of this research  
(Shaded indicates the 68 participants used in this study) 
3.2 Intervention Protocols 
Patients are referred to the University Of Waterloo School Of 
Optometry Low Vision Clinic by a variety of methods including self-referral, 
optometrists, ophthalmologists, organizations (such as the CNIB), physicians, 
service organizations, rehabilitation facility schools, and word of mouth. The 
clinic’s goal is to maintain or improve functional status as well as to enhance 
psychosocial well-being through interventions involving several trained 
professionals of the rehabilitation team (optometrist, high technology 
assessment specialist, rehabilitation worker, and social worker).63 Patients are 
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required to complete intake paperwork prior to their appointment to better 
understand their goals and objectives. 
During appointments, patients have the possibility of seeing a variety 
of people. See Table 2 for services available at the Low Vision Clinic. 








- Functional history 
- Education and emotional support 
- Assessment of visual abilities: visual acuity, contrast sensitivity, 
visual field, colour vision, glare sensitivity, refraction 
- Determination of assistive optical and non-optical systems 
- Recommendations for rehabilitation and communication with the 
rehabilitation team 
- Registration with ADP funding program 
- Prescription of devices 
Rehabilitation 
Worker 
Evaluation and Training in: 
- Prescribed optical devices 
- Non-optical adaptive devices 
- Provides daily living skills 
- Demonstrating techniques and teaching concepts to assist in 
educational, occupational, recreational, daily living, social and 
leisure activities 
- Environmental modifications (i.e.) marking items, lighting, 
colour contrast and organization 
- Basic sighted guide techniques 
- Systemic tracking, scanning, localizing  
- Assistance with maintaining independence 





- Client assessment with video, CCTV, and computer based 
devices 
- Outcome recommendations 
- Authorize government funding for eligible clients 




- Provide individual and family counselling to help clients and 
their families cope with progressive vision loss 
- Referral to community resources 
- Advocacy 
- Provide additional or follow-up counselling to those interested 
(either at the clinic or telephone counselling) 
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The Assistive Devices Program (ADP) is a highly successful Ontario 
government initiative that provides significant levels of funding support 
toward the purchase of any assistive devices that have been duly prescribed 
and authorized for Ontario residents with disabilities.64 These include both 
high and low technology rehabilitation devices in the categories of augmented 
communication, respiration, mobility, ostomy, hearing, seating, prosthetic, 
orthotics, and vision. Program consultants were asked to develop a series of 
sound and defensible protocols for the assessment and training of all clients 
being seen, regardless of the presentation or service/device needs.32 The ADP 
program is used at the Low Vision Clinic in the prescription of CCTV 
devices.  
CCTV systems are demonstrated to interested and suitable low vision 
patients with vast range of acuity impairments. There are many generic 
features of CCTV devices, however many patients are also sensitive to other 
more particularized and subtle features that may improve their comfort, speed, 
facility, and endurance while using a CCTV.32 The overall goal is to provide 
patients with an opportunity to use each system in the way that they expect to 
use it after they purchase it.32 
3.3 Measurements and Data Collection 
All data collection was performed over the telephone and all clinical 
information was obtained from clinic files. The instruments used were the 
National Eye Institute Visual Function Questionnaire (NEI VFQ-25) and the 
Psychosocial Impact of Assistive Devices Scale (PIADS) (see Appendix). 
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Four (4) time periods were analyzed for this thesis. Both the PIADS and the 
NEI VFQ-25 were conducted at 2 weeks, 1 month, 3 months, and 6 months 
post-adoption of the CCTV. From the clinic files the age, sex, support level, 
living circumstance and distribution of eye conditions were collected. 
Participant’s level of education was asked during the first assessment. 
3.4 Data Analysis  
The recommended NEI VFQ-25 scoring algorithms, which consist of 
linear transformations of raw scores for each of 12 domains, were calculated 
as per the instructions provided with the NEI VFQ-25. The 12 subscales were 
general health, general vision, ocular pain, near activities, distance activities, 
social functioning, mental health, role difficulties, dependency, driving, colour 
vision, and peripheral vision. The PIADS subscale score for competence, 
adaptability, and self-esteem were calculated as per instructions in the manual. 
All data analysis was done through SPSS version 15.0. Multivariate repeated-
measures ANOVA was performed on the subscales for each measurement tool 
separately to see if there is a significant change in the NEI VFQ-25 results 
post adoption of CCTV system and then to see if there is a change in PIADS 
over the four time periods. Multivariate repeated-measures ANOVA is an 
appropriate test since there are more than one dependent variables (multiple 
variable in each of the subscales) and these multiple dependent variables are 
being tested over a period of time (four time intervals).65  
To see if the NEI VFQ-25 scores were stable over time, we tested the 
null hypothesis that the mean differences within pairs of NEI VFQ-25 
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subscales scores were zero. If the results were not zero, we would assume a 
change had occurred and post-hoc tests would be applied to see where the 
change had occurred. Multivariate repeated-measures ANOVA tests were then 
done with the PIADS subscales items to see if the mean difference within 
pairs were zero.  If the results of the PIADS’ mean differences were not zero, 
post-hoc tests were preformed to see where the change had occurred. 
Significance was set at a p-value of less than 0.05. 
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Chapter 4: Results  
4.1 Study Participants 
All of the 68 participants were obtained from the ongoing cohort 
CIHR funded study entitled “Dynamic program approach to modeling 
assistive technology device outcomes in low vision rehabilitation” (PIs: Dr. J. 
Jutai, Dr. G. Strong, Dr. H. Ariizumi, and Dr. A. Plotkin). They were first 
time users of the CCTV system, and were diagnosed with either wet or dry 
ARMD.  The distribution of age and gender, education, support, living 
circumstance, and eye condition can be seen in Figure 4, Figure 5, Figure 6, 
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Figure 8: Profile of eye conditions  
(Black indicates types of ARMD, pattern indicates other diagnoses) 
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4.2 NEI VFQ-25 Results 
Descriptive statistics from the NEI VFQ-25 are provided in Table 3. 
These results are for all 68 participants post adoption of their CCTV device 
and were normally distributed. There were several questions which resulted in 
no answer from some of the participants. This is seen especially in the driving 
category where a large majority of the participants were no longer legally 
allowed to drive, therefore could not answer those questions. The NEI VFQ-
25 results indicate that, functional status is stable following adoption of a 
CCTV device. 
Table 3: Descriptive statistics of NEI VFQ-25 for the four time periods.  
(Where 1 = 2 weeks, 2 = 1 month, 3 = 3 months, 4 = 6 months post-adoption 
of CCTV) 
  
  N Mean 
Std. 
Deviation 
VFQ Subscore General Health 1 68 53.31 28.94
VFQ Subscore General Vision 1 68 47.06 18.21
VFQ Subscore Ocular Pain 1 68 88.24 20.59
VFQ Subscore Near Activities 1 68 54.60 22.41
VFQ Subscore Distance Activities 1 68 49.75 22.64
VFQ Subscore Social Functioning 1 68 53.31 25.34
VFQ Subscore Mental Health 1 68 50.83 27.63
VFQ Subscore Role Difficulties 1 68 40.07 28.45
VFQ Subscore Dependency 1 68 56.37 30.00
VFQ Subscore Driving 1 49 1.96 10.03
VFQ Subscore Colour Vision 1 68 72.43 31.19
VFQ Subscore Peripheral Vision 1 67 83.21 28.33
VFQ Subscore General Health 2 68 54.78 26.01
VFQ Subscore General Vision 2 68 46.76 13.21
VFQ Subscore Ocular Pain 2 68 89.15 16.85
VFQ Subscore Near Activities 2 68 56.07 22.22
VFQ Subscore Distance Activities 2 68 47.98 21.55
VFQ Subscore Social Functioning 2 68 52.76 23.14
VFQ Subscore Mental Health 2 68 55.70 24.62
VFQ Subscore Role Difficulties 2 68 36.21 28.34
VFQ Subscore Dependency 2 68 56.62 29.98
VFQ Subscore Driving 2 50 2.00 10.45
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VFQ Subscore Colour Vision 2 68 74.63 30.99
VFQ Subscore Peripheral Vision 2 68 81.62 26.49
VFQ Subscore General Health 3 68 53.31 27.96
VFQ Subscore General Vision 3 68 46.76 15.30
VFQ Subscore Ocular Pain 3 68 89.34 18.36
VFQ Subscore Near Activities 3 68 52.57 22.27
VFQ Subscore Distance Activities 3 67 47.39 23.32
VFQ Subscore Social Functioning 3 68 51.29 21.61
VFQ Subscore Mental Health 3 68 53.58 23.79
VFQ Subscore Role Difficulties 3 67 28.36 25.15
VFQ Subscore Dependency 3 68 49.51 28.90
VFQ Subscore Driving 3 52 2.88 15.38
VFQ Subscore Colour Vision 3 68 66.54 33.07
VFQ Subscore Peripheral Vision 3 68 83.46 26.84
VFQ Subscore General Health 4 68 48.16 28.43
VFQ Subscore General Vision 4 68 44.41 15.39
VFQ Subscore Ocular Pain 4 68 88.42 18.11
VFQ Subscore Near Activities 4 68 52.21 20.39
VFQ Subscore Distance Activities 4 68 46.45 23.17
VFQ Subscore Social Functioning 4 68 51.29 20.28
VFQ Subscore Mental Health 4 68 53.86 26.10
VFQ Subscore Role Difficulties 4 68 31.43 30.66
VFQ Subscore Dependency 4 68 51.47 29.54
VFQ Subscore Driving 4 52 4.01 17.66
VFQ Subscore Colour Vision 4 68 65.81 32.01
VFQ Subscore Peripheral Vision 4 68 81.99 22.38
Valid N (listwise) 47    
 
Paired T-tests were performed on the NEI VFQ-25 subscales between 
2 weeks and 1 month, between 1 month and 3 months, between 3 months and 
6 months, and between 2 weeks and 6 months (see Table 4). Bonferroni 
correction concerns the question if the alpha level should be adjusted 
downward to consider chance capitalization (in the case of doing more than 
one test in a particular study).66 The alpha level (0.05) was adjusted to a level 
of 0.00416. The NEI VFQ-25 subscales did not reveal any significant change 
over the six months of follow-up post adoption of CCTV. 
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Table 4: Results from the paired T-test for the 12 NEI VFQ-25 subscale 
items 
 T Df P 
General Health 
Initial – 1 month -0.59 67 .559
1 month- 3 months 0.48 67 .631
3 months - 6 months 1.94 67 .056
Initial – 6 months 1.65 67 .104
General Vision 
Initial – 1 month 0.16 67 .874
1 month- 3 months 0.00 67 1.000
3 months - 6 months 1.43 67 .159
Initial – 6 months 1.04 67 .302
Ocular Pain 
Initial – 1 month -0.46 67 .647
1 month- 3 months -0.10 67 .923
3 months - 6 months 0.42 67 .677
Initial – 6 months -0.08 67 .939
Near Activities 
Initial – 1 month -0.68 67 .497
1 month- 3 months 1.26 67 .212
3 months - 6 months 0.17 67 .864
Initial – 6 months 0.75 67 .459
Distance Activities 
Initial – 1 month 0.96 67 .339
1 month- 3 months 0.44 66 .664
3 months - 6 months 0.12 66 .909
Initial – 6 months 1.20 67 .236
Social Functioning 
Initial – 1 month 0.30 67 .765
1 month- 3 months 0.59 67 .555
3 months - 6 months 0.00 67 1.000
Initial – 6 months 0.69 67 .493
Mental Health 
Initial – 1 month -2.17 67 .034
1 month- 3 months 0.90 67 .372
3 months - 6 months -0.12 67 .904
Initial – 6 months -1.13 67 .264
Role Difficulties 
Initial – 1 month 1.34 67 .185
1 month- 3 months 2.18 66 .033
3 months - 6 months -1.10 66 .275
Initial – 6 months 1.81 67 .075
Dependency  
Initial – 1 month -0.09 67 .931
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1 month- 3 months 2.23 67 .029
3 months - 6 months -0.74 67 .464
Initial – 6 months 1.53 67 .130
Driving 
Initial – 1 month -0.09 47 .926
1 month- 3 months -0.47 49 .644
3 months - 6 months -1.41 51 .164
Initial – 6 months -0.15 48 .881
Colour Vision 
Initial – 1 month -0.93 67 .358
1 month- 3 months 2.22 67 .030
3 months - 6 months 0.21 67 .837
Initial – 6 months 1.79 67 .077
Peripheral Vision 
Initial – 1 month 0.61 66 .545
1 month- 3 months -0.70 67 .488
3 months - 6 months 0.57 67 .568
Initial – 6 months 0.41 66 .686
 
The results of the NEI VFQ-25 over the six-month period can be seen 
graphically in Figure 9. While some mean subscale scores were higher than 






















Figure 9: Error Bar Plot of NEI VFQ-25 Subscale items during the 6 
months  
− General Health − General Vision − Ocular Pain− Near Activities  − Distance Activities − Social Functioning − Mental Health  − Role Difficulties  − Dependency − Driving   − Colour Vision  − Peripheral Vision  







4.3 PIADS Results 
The descriptive statistics from the PIADS subscales are presented in 
Table 7. These are results for all 68 participants post adoption of their CCTV 
device. They are normally distributed. For the PIADS questionnaire, all 
(100%) of the questions were answered. These data indicate a positive 
psychosocial impact upon receiving a CCTV device. 
Table 5: Descriptive statistics for the PIADS subscales for the 6 months 
period.  
(Where 1 = 2 weeks, 2 = 1 month, 3 = 3 months, and 4 = 6 months post-
adoption of the CCTV) 
  
  N Mean 
Std. 
Deviation 
PIADS Subscale Competence 1 68 1.39 0.69
PIADS Subscale Adaptability 1 68 1.05 0.66
PIADS Subscale Self-Esteem 1 68 1.05 0.62
PIADS Subscale Competence 2  68 1.41 0.68
PIADS Subscale Adaptability 2 68 1.15 0.62
PIADS Subscale Self-Esteem 2 68 1.10 0.60
PIADS Subscale Competence 3 68 1.33 0.73
PIADS Subscale Adaptability 3 68 1.02 0.68
PIADS Subscale Self-Esteem 3 68 1.06 0.59
PIADS Subscale Competence 4 68 1.21 0.83
PIADS Subscale Adaptability 4 68 0.76 0.68
PIADS Subscale Self-Esteem 4 68 0.99 0.76
Valid N (listwise) 68   
 
Multivariate repeated-measures ANOVA preformed on the PIADS 
subscales reveal that no significant difference throughout the six-month time 
frame in the self-esteem or competence subscales. However, there was a 





Table 6: Repeated-measures ANOVA for the three subscales of the 
PIADS. 
Competence 





Participant 1.64 3 0.55 2.36 .073
Error 46.53 201 0.23   
Adaptability 





Participant 5.54 3 1.85 7.31 1.119x10-4
Error 50.77 201 0.25  
Self-Esteem 





Participant 0.36 3 0.12 0.67 .569
Error 35.99 201 0.18   
 
These results can be seen graphically in Figure 10 where we see a peak 
in the psychosocial impact of the devices at the one month interval for all 
three subscales. This is follow by attenuation for all subscales. However, the 



















− Competence  −Adaptability  −Self-Esteem 
Where 1 = 2 weeks, 2 = 1 month, 3 = 3 months, and 4 = 6 months 
post-adoption of CCTV
Figure 10: Estimated marginal means for the three subscale items of the 
PIADS 
 
Paired T-tests were performed on the PIADS subscales between 2 
weeks and 1 month, between 1 month and 3 months, between 3 months and 6 
months, and between 2 weeks and 6 months (see Table 7). Bonforroni 
adjustment was applied to the alpha level (0.05) to a level of 0.0167. The 
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results reveal that there was a significant difference in the adaptability 
subscale around the 3 and 6 month time period post adoption of the CCTV. 
Table 7: Paired T-test results of the PIADS subscale items 
Df = 67 T P 
Competence 
Initial – 1 month -0.26 .794 
1 month – 3 months 1.02 .313 
3 months – 6 months 1.47 .147 
Initial – 6 months 1.92 .060 
Adaptability 
Initial – 1 month -1.18 .244 
1 month – 3 months 1.46 .148 
3 months – 6 months 3.60 .001*** 
Initial – 6 months 2.99 .004*** 
Self-Esteem 
Initial – 1 month -0.88 .383 
1 month – 3 months 0.49 .625 
3 months – 6 months 1.00 .321 
Initial – 6 months 0.66 .514 
4.4 Gender 
When the results were separated for males and females, there was no 
significant difference between the PIADS results for the two genders (See 
Table 8 and Figure 11) 




Squares df Mean Square F Sig. 
Gender 0.37 1 0.37 0.120 0.73





















Time                                                                                                Time
 
                
− Competence  −Adaptability  −Self-Esteem 
Where 1 = 2 weeks, 2 = 1 month, 3 = 3 months, and 4 = 6 months 
post-adoption of CCTV
Figure 11: PIADS subscales results for either male or female  
 
4.5 Wet versus Dry age-related macular degeneration 
When the results were separated for type of ARMD, it was shown that 
there was no significant difference between Wet ARMD and Dry ARMD. 
Although wet ARMD has slightly higher results than dry, these differences are 
not statistically significant. This can be seen in the between participant effects 










Square F Sig. 
Diagnosis 1.37 1 1.37 0.44 .051



















          
− Competence  −Adaptability  −Self-Esteem 
Where 1 = 2 weeks, 2 = 1 month, 3 = 3 months, and 4 = 6 months 
post-adoption of CCTV
 
Figure 12: PIADS subscales results for participants with either wet or dry 
ARMD  
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Chapter 5: Discussion 
5.1 CCTV Adoption and Impact on Visual Function 
The results from the NEI VFQ-25 survey indicate subjective visual 
functioning stabilizes post CCTV adoption. Although some mean subscale 
scores were higher than others, the mean scores did not change significantly 
following six-months of post CCTV adoption (see Table 4 and Figure 9).  
The results from this research complement and extend current research 
on CCTV adoption and impact on visual function. The study by Brody et al. 
(2005) focused on a six-month follow up of patients with advanced ARMD 
after they had undergone treatments based on a 12-hour self management 
program.67 This study was with 8 to 10 participants and the components of the 
12-hour self management program focused on cognitive elements (including 
information about ARMD, services, reevaluation of barriers, and positive 
challenges) and behavioral elements (communication about ARMD, problem 
solving using vignettes, modeling of adaptive behaviors, and a simple exercise 
program). 67 Using the NEI VFQ-25, Brody et al. (2005) found increased 
visual functioning in patients from baseline to the six-month follow up.67 It is 
important to note, however, that the study by Brody et al. (2005) specifically 
identified patients with advanced ARMD, their results were not based on 
device outcome, and only one follow-up was conducted at the 6 month follow 
up time. The study by Brody et al. (2005) differs from this study in that they 
focused on a rehabilitation program and not on device adoption. In addition 
their results were comparing baseline results and follow-up at six-months; 
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they were not looking at the changes that occur over the six-month time. It is 
interesting to speculate whether the results Brody et al.’s (2005) would change 
if assessments were measured at intervals. 
Results from this study also are consistent with findings reported by 
Stelmack et al. (2002) who used the NEI VFQ-25. Stelmack et al. (2002) used 
NEI VFQ-25 to compare two low vision programs and their rehabilitation 
procedures. Their results demonstrated that the NEI VFQ-25 was effective at 
measuring the effects of rehabilitation, but they reported that a subset of the 
NEI VFQ-25 items were sensitive to change after rehabilitation for a low 
vision population.31 Their measurements were taken at the conclusion of the 
rehabilitation program, just prior to patients discharge. Again, these results are 
based on a single assessment and the participants were still in the program (or 
just about to leave) when the measurements were taken. It seems possible that 
there may be changes in response to the questions after the participants 
returned to their daily tasks in their own homes. Nonetheless, the NEI VFQ-25 
results of this study of ARMD participants are similar to those reported by 
Stelmack et al. (2002) for their low vision population. 
Another similar study, conducted by Scilley et al. (2004), used 
telephone interviews with ARMD participants approximately two weeks after 
they received low vision rehabilitation and low vision assistive devices.7 
Participants were diagnosed with wet or dry ARMD as in my research. The 
NEI VFQ-25 scores in my study are consistent with those reported by Scilley 
et al. (2004) who found that ARMD patients who seek out low vision services 
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have significantly diminished vision specific quality of life as measured by the 
NEI VFQ-25.7 Although their study was not specific to CCTV devices, 
Scilley et al. (2004) reported results that are similar to those of my study. 
Therefore, the results of the NEI VFQ-25 in this thesis are consistent 
with the results of previous studies pertaining to low vision participants. We 
believe that these results indicate stabilized visual function following adoption 
of the CCTV device.7, 31, 67  
5.2 Psychosocial Impact Following CCTV Adoption 
The results from PIADS reveal a positive psychosocial impact that is 
attributable to the adoption of a CCTV. As indicated in Table 7 and Figure 10, 
positive psychosocial impact peaks at a maximum value at approximately one 
month following adoption and subsequently attenuates after one month. 
These PIADS results are consistent with the results in other research 
studies. Jutai et al. (2000) found the use of electronic aids had a positive 
psychosocial impact on daily living for participants with degenerative 
neuromuscular disorders.57 However, Jutai et al. (2000) found that the positive 
impact remained stable over time. A consideration for the stability in the 
PIADS results is that the participants had longer experience time with their 
devices and therefore were accommodated to any potential changes 
(participants had an average of four years experience with their electric aids).  
Another study investigating the psychosocial impact of devices was 
done by Day et al. (2001). Day et al. (2001) study examined the PIADS 
results for participants with newly acquired prescription glasses. Participants 
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were asked to complete the surveys at two months and then one year post 
adoption of their prescription glasses.38 The study by Day et al. (2001) were 
similar to my study because their results indicated positive psychosocial 
impact upon adoption of prescription glasses; however their results did not 
diminish over time as it did in my study.38 One possibility for these results (as 
similar to the Jutai et al. 2000) is that these participants may have had been 
exposed to the use of prescription glasses prior to this study and may have 
anticipated the impact of the glasses, therefore no change would be apparent. 
As well, there were only two time measurements taken and small changes in 
the psychosocial impact may not have been reflected. 
Strong et al. (2004) assessed the psychosocial impact of CCTV 
devices on low vision participants over three years using a similar design to 
this study.32 My study results are similar to the results of psychosocial impact 
reported in the study by Strong et al. (2004). Strong et al. (2004) also 
experienced an attenuation of scores, the most significant being in the third 
year.32 The results presented in this thesis further validate and extend the 
research reported by Strong et al. (2004). Due to the more specific design of 
the current study we were able to detect a more precise map of the changes in 
psychosocial impact upon receiving CCTV devices compared to the yearly 
assessments of the Strong et al. (2004) study. 
The results of this current research add to evidence of the validity of 
previous work. Therefore we believe that psychosocial impact upon adoption 
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of a CCTV is positive and these results are dynamic post adoption and they 
attenuate as time goes on.32, 38, 57  
5.3 Confounding Factors (Gender and Type of ARMD) 
The differences in gender did not influence the results of the 
measurement tools (see Figure 11). This was expected based on previous 
studies.32 
The results from the separation of wet and dry ARMD indicate no 
significant changes; however it does appear that wet ARMD participants 
reported a slightly higher psychosocial impact from CCTV use (see Figure 
12). This difference could be attributable to the severity of their condition. 
Wet ARMD produces a sudden, dramatic loss of central vision compared to 
dry ARMD (which is more gradual and slow in progression).19 People with 
dry ARMD have a longer time to adapt to smaller and gradual changes. Since 
wet ARMD is more severe compared to dry ARMD we may except to see a 
slightly higher psychosocial impact of CCTV devices; however, this requires 
further investigation.  
5.4 Limitations 
The validity of the NEI VFQ-25 for an elderly population with low 
vision has been debated.7, 31 It is believed that lower scores are recorded 
compared with other NEI VFQ-25 results due to the fact that the questions 
may not adequately represent the rehabilitation needs of patients with low 
vision over the range of vision loss in this population.31 For example, three 
items are relevant to mobility (going down steps/curbs, peripheral vision, and 
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taking part in active sports) and these mobility-related activities are not 
expected to change in response to adoption of a CCTV. 31 
As well, the participant instructions for the NEI VFQ-25 questionnaire 
state “the next questions are about how much difficulty, if any, you have 
doing certain activities wearing your glasses or contact lenses if you use them 
for that activity”. These directions were modified for the assessment 
interviews to add consideration of use of CCTV devices.  
The PIADS posed several problems based on patient interpretation of 
concepts. Some subjects reported difficulty with the PIADS when 
administered over the telephone and they felt many of the questions were 
repetitive or inapplicable to their lifestyle (i.e. self-esteem versus self-
confidence, willingness to make changes versus ability to take advantage of 
opportunities, sense of control, and productivity). 
5.5 Clinical Significance 
This study provides insight into the content and timing of follow-up 
services and outcomes following device assisted rehabilitation. One 
possibility for clinical changes is that the NEI VFQ-25 could be administered 
prior to patients’ appointments to assess and quantify functional vision 
deficits. By administering the NEI VFQ-25 and the PIADS after their 
appointment, clinicians could then verify if they have addressed and improved 
the patients concerns. By comparing the NEI VFQ-25 pre- and post-
assessment, the results could be used to see if the services and/or devices 
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altered perceived functional vision status. The PIADS can be used to measure 
the psychosocial impact the device had on the patient.  
By understanding that attenuation occurs following one month of 
CCTV usage, the clinic might consider a follow-up appointment around the 
one month period to ensure that the patient is still satisfied with their device. It 
may be that patients are satisfied with their device and it is the impact of the 
CCTV that has diminished (not device satisfaction). Providing a follow-up 
will clearly distinguish if there is dissatisfaction with the device or if there is a 
change in the impact of the device that is affecting the attenuation. 
Also, traditional methods to test how well a patient can see have been 
the norm for a very long time (such as visual acuity, contrast sensitivity test, 
and visual field tests), but we are encountering a more ‘patient-centered’ view 
in clinical practice in order to understand the impact of rehabilitation on a 
patients’ entire life. With the above results, patients are not expressing a 
change in their visual function (as shown with NEI VFQ-25), but the PIADS 
reveals that there are changes occurring as reported by patients’ psychosocial 
impact. Clinicians need to be aware of these changes in order to better 
comprehend the impact of ARMD and rehabilitation on patients’ lives. 
5.6 Future Direction 
The results of this study leave several questions unanswered. The 
reasons for the eventual attenuation of PIADS scores are not clear, but the 
stable NEI VFQ-25 results suggest that it is not caused by any perceived 
changes in visual function. Future research should investigate why attenuation 
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occurs and whether it presents an important opportunity for intervention. One 
possibility is that attenuation represents a response shift, wherein patients 
undergo a change in health state that changes their internal standards, their 
values, or the conceptualization of quality of life.45 As their ‘new normal’ 
baseline for estimating device impact becomes elevated over time, the amount 
of perceived impact measured by the PIADS is diminished. This same 
prediction has been made by Strong et al. (2004).32 There are several theories 
as to response shift (related to stress and coping, related to suppression of the 
relation between physical health and quality of life, and/or related to personal 
goals) and investigation into these theories may provide insight as the 
reasoning for the attenuation.45  
Another possibility is that the ‘competitive enablement’ approach to 
low vision assessment and the selection process for CCTV systems, allows the 
patients to develop realistic expectations about the impact of the CCTV. This 
phenomenon has also been seen in patients with amyotrophic lateral sclerosis 
(ALS) using writing aids.68 Jutai (2001) found there was little difference 
between PIADS responses over time due to the fact that users were able to 
accurately anticipate the benefit of their device use.68 
This research provides further agreement in the argument that the NEI 
VFQ-25 may not be very sensitive to changes in low vision participants, in 
that the NEI VFQ-25 did not detect any changes over six-months. Further 
research into providing a sufficient measurement tool to measure visual 
function for low vision participants could be investigated.  
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Chapter 6: Conclusions 
This study provides insight into the importance of investigating 
longitudinal outcomes experienced by people with ARMD-related low vision 
who have obtained a CCTV through a competitive enablement assessment. 
These outcomes may lead to knowledge for the development of rehabilitation 
interventions which may diminish the limitations created by vision loss. This 
may be accomplished by understanding how a person’s psychosocial status 
changes over six months after receiving a CCTV device. The results are 
consistent with the CATOR framework, which implies that changes in activity 
(such as those related to assistive device intervention as revealed by the NEI-
VFQ-25) may precede changes in participation (as revealed by PIADS).   
In response to the proposed hypotheses: CCTV systems appear to have 
an immediate and positive impact on the functional status of their users that 
remains stable following six-months of follow-up (as shown through the NEI 
VFQ-25). The psychosocial impact of CCTV devices was shown to be 
positive with a peak impact around the one-month follow-up which was 
followed by decreased scores into the six-months of follow-up (as shown 
through the PIADS). 
This project shows that CCTV devices are effective in improving the 
psychosocial status of patients with age-related macular degeneration.  It is 
clear that CCTV devices “provide a means to circumvent barriers and 
subsequently increasing active participation. Increased participation provides 
the basis to cope and adapt to barriers, and can enhance the quality of life”.34 
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